{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:51:03Z","timestamp":1790848263426,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The use of iodinated contrast media (ICM) can lead to thyrotoxicosis, especially in patients with risk factors, such as Graves\u2019 disease, multinodular goiter, older age, and iodine deficiency. Although hyperthyroidism may have clinically relevant effects, whether high-risk patients should receive prophylactic treatment before they are administered ICM is still debated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim of the study<\/jats:title><jats:p>We aimed to demonstrate the safety and efficacy of prophylactic treatment with sodium perchlorate and\/or methimazole to prevent ICM-induced hyperthyroidism (ICMIH) in a population of high-risk cardiac patients. We ran a cost analysis to ascertain the most cost-effective prophylactic treatment protocol. We also aimed to identify possible risk factors for the onset of ICMIH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We performed a longitudinal retrospective study on 61 patients admitted to a tertiary-level cardiology unit for diagnostic and\/or therapeutic ICM-procedures. We included patients with available records of thyroid function tests performed before and after ICM were administered, who were at high risk of developing ICMIH. Patients were given one of two different prophylactic treatments (methimazole alone or both methimazole and sodium perchlorate) or no prophylactic treatment. The difference between their thyroid function at the baseline and 11-30 days after the ICM-related procedure was considered the principal endpoint.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-three (38%) of the 61 patients were given a prophylactic treatment. Thyroid function deteriorated after the administration of ICM in 9\/61 patients (15%). These cases were associated with higher plasma creatinine levels at admission, higher baseline TSH levels, lower baseline FT4 levels, and no use of prophylactic treatment. The type of prophylaxis provided did not influence any onset of ICMIH. A cost-benefit analysis showed that prophylactic treatment with methimazole alone was less costly per person than the combination protocol. On multivariate analysis, only the use of a prophylactic treatment was independently associated with a reduction in the risk of ICMIH. Patients not given any prophylactic treatment had a nearly five-fold higher relative risk of developing ICMIH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prophylactic treatment can prevent the onset of ICMIH in high-risk populations administered ICM. Prophylaxis is safe and effective in this setting, especially in cardiopathic patients. Prophylaxis with methimazole alone seems to be the most cost-effective option.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1154251","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:57:02Z","timestamp":1684162622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population"],"prefix":"10.3389","volume":"14","author":[{"given":"Jacopo","family":"Manso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Clausi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Merante Boschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","first-page":"97","article-title":"Acr manual on contrast media: 2018 updates","volume":"91","author":"Kodzwa","year":"2019","journal-title":"Radiol Technol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ndt\/gfh1068","article-title":"Editorial: contrast medium-induced nephropathy","volume":"20","author":"Persson","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.677","article-title":"Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism","volume":"172","author":"Rhee","year":"2012","journal-title":"Arch Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2006.06.020","article-title":"European Society of urogenital radiology (Esur) guidelines on the safe use of iodinated contrast media","volume":"60","author":"Thomsen","year":"2006","journal-title":"Eur J Radiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)57335-X","article-title":"Plasma inorganic iodide as a homeostatic regulator of thyroid function","volume":"174","author":"Wolff","year":"1948","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3292","article-title":"A review: radiographic iodinated contrast media-induced thyroid dysfunction","volume":"100","author":"Lee","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082399","article-title":"Changing dietary habits in veneto region over two decades: still a long road to go to reach an iodine-sufficient status","volume":"12","author":"Censi","year":"2020","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-004-2238-z","article-title":"Contrast media safety committee ESoUR. effect of iodinated contrast media on thyroid function in adults","volume":"14","author":"van der Molen","year":"2004","journal-title":"Eur Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0002-9343(93)90235-h","article-title":"Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly","volume":"95","author":"Martin","year":"1993","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0051","article-title":"Iodinated contrast media-induced thyroid dysfunction in euthyroid nodular goiter patients","volume":"26","author":"Kornelius","year":"2016","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/thy.1998.8.83","article-title":"Iodine-induced hyperthyroidism: occurrence and epidemiology","volume":"8","author":"Stanbury","year":"1998","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12376","article-title":"Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it","volume":"80","author":"Hudzik","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","article-title":"Comparison and assessment of thyroid morphology and function in inhabitants of lower Silesia before and after administration of a single dose of iodine-containing contrast agent during cardiac intervention procedure","volume":"63","author":"Skorkowska-Telichowska","year":"2012","journal-title":"Endokrynol Pol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0459","article-title":"Prevalence of iodine-induced hyperthyroidism after administration of iodinated contrast during radiographic procedures: a systematic review and meta-analysis of the literature","volume":"31","author":"Bervini","year":"2021","journal-title":"Thyroid"},{"key":"B15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0021-9258(19)52781-8","article-title":"The inhibitory action of iodide upon organic binding of iodine by the normal thyroid gland","volume":"172","author":"Wolff","year":"1948","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01303.x","article-title":"The toxic effect of small iodine supplements in patients with autonomous thyroid nodules","volume":"7","author":"Livadas","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3283565bb2","article-title":"Iodine-induced thyroid dysfunction","volume":"19","author":"Leung","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/105072501300176453","article-title":"Iodine excess and hyperthyroidism","volume":"11","author":"Roti","year":"2001","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2013.38685","article-title":"Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology","volume":"9","author":"Ertek","year":"2013","journal-title":"Arch Med Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760143854","article-title":"Hyperthyroidism and cardiovascular morbidity and mortality","volume":"12","author":"Osman","year":"2002","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.105","article-title":"Cardiovascular involvement in patients with different causes of hyperthyroidism","volume":"6","author":"Biondi","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01590-9","article-title":"Thyroid and heart, a clinically relevant relationship","volume":"44","author":"Corona","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000517175","article-title":"European Thyroid association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction","volume":"10","author":"Bednarczuk","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B25","article-title":"[Prevention of iodine-induced hyperthyroidism after coronary angiography]","volume":"20","author":"Fritzsche","year":"1993","journal-title":"Acta Med Austriaca"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1340337","article-title":"Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study","volume":"134","author":"Nolte","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0728","article-title":"Scintigraphy for risk stratification of iodine-induced thyrotoxicosis in patients receiving contrast agent for coronary angiography: a prospective study of patients with low thyrotropin","volume":"89","author":"Fricke","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000515126","article-title":"Prevention of iodinated contrast media-induced hyperthyroidism in patients with euthyroid goiter","volume":"10","author":"Pelewicz","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"American Thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13494","article-title":"Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: long-term follow-up and influence of baseline thyroid functional status","volume":"88","author":"Bonelli","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0099","article-title":"One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy","volume":"22","author":"Padovani","year":"2012","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1154251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:57:07Z","timestamp":1684162627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1154251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":31,"alternative-id":["10.3389\/fendo.2023.1154251"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1154251","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1154251"}}